Neutrophil-to-lymphocyte ratio as a predictive biomarker for moderate-severe ARDS in severe COVID-19 patients
Trial registration ChiCTR, ChiCTR2000029758. Registered 12 February 2020 - Retrospectively registered
Main Authors: | Aijia Ma, Jiangli Cheng, Jing Yang, Meiling Dong, Xuelian Liao, Yan Kang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-06-01
|
Series: | Critical Care |
Online Access: | http://link.springer.com/article/10.1186/s13054-020-03007-0 |
Similar Items
-
Neutrophil-to-Lymphocyte ratio as a potential biomarker for disease severity in COVID-19 patients
by: Shaghayegh Haghjooy Javanmard, et al.
Published: (2020-09-01) -
NEUTROPHIL TO LYMPHOCYTE RATIO VS PLATELETS TO LYMPHOCYTE RATIO: BIOMARKERS TO PREDICT SEVERITY OF DISEASE AND THEIR COMPARISON IN PATIENTS OF COVID-19
by: Muhammad Adil, et al.
Published: (2020-12-01) -
Neutrophil-to-Lymphocyte Ratio and Covid-19 Symptom-based Severity at Admission
by: M. Fuad, et al.
Published: (2021-03-01) -
Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio and Their Role as Predictors of Disease Severity of Coronavirus Disease 2019 (COVID-19)
by: Rohit Jain, et al.
Published: (2021-02-01) -
Neutrophil-to-Lymphocyte Ratios Are Closely Associated With the Severity and Course of Non-mild COVID-19
by: Sen Qun, et al.
Published: (2020-09-01)